Lion Street Advisors LLC Decreases Holdings in Veeva Systems Inc. $VEEV

Lion Street Advisors LLC decreased its position in shares of Veeva Systems Inc. (NYSE:VEEVFree Report) by 7.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,280 shares of the technology company’s stock after selling 173 shares during the period. Lion Street Advisors LLC’s holdings in Veeva Systems were worth $657,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. MGO One Seven LLC lifted its position in Veeva Systems by 22.0% during the second quarter. MGO One Seven LLC now owns 3,992 shares of the technology company’s stock valued at $1,150,000 after acquiring an additional 719 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in Veeva Systems by 4.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 82,405 shares of the technology company’s stock valued at $23,312,000 after purchasing an additional 3,156 shares in the last quarter. Alta Advisers Ltd acquired a new position in Veeva Systems during the 2nd quarter valued at approximately $231,000. CWM LLC increased its stake in Veeva Systems by 215.8% during the 2nd quarter. CWM LLC now owns 27,745 shares of the technology company’s stock valued at $7,990,000 after purchasing an additional 18,960 shares in the last quarter. Finally, OFI Invest Asset Management increased its stake in Veeva Systems by 31.8% during the 2nd quarter. OFI Invest Asset Management now owns 443 shares of the technology company’s stock valued at $128,000 after purchasing an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insider Buying and Selling

In related news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total transaction of $1,005,134.00. Following the sale, the insider directly owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the sale, the insider directly owned 25,325 shares in the company, valued at $7,765,151.50. This trade represents a 19.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 24,665 shares of company stock valued at $7,438,000. Corporate insiders own 10.30% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have issued reports on VEEV. JPMorgan Chase & Co. upgraded shares of Veeva Systems from a “neutral” rating to an “overweight” rating and upped their price target for the company from $290.00 to $330.00 in a research note on Monday, September 8th. Barclays upped their price target on shares of Veeva Systems from $300.00 to $325.00 and gave the company an “overweight” rating in a research note on Thursday, August 28th. Citigroup upped their price target on shares of Veeva Systems from $329.00 to $349.00 and gave the company a “buy” rating in a research note on Thursday, August 28th. UBS Group upped their price target on shares of Veeva Systems from $285.00 to $310.00 and gave the company a “neutral” rating in a research note on Thursday, August 28th. Finally, Wall Street Zen upgraded shares of Veeva Systems from a “hold” rating to a “buy” rating in a research note on Saturday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $307.58.

Read Our Latest Research Report on VEEV

Veeva Systems Price Performance

NYSE:VEEV opened at $287.04 on Monday. The firm has a market capitalization of $47.05 billion, a P/E ratio of 58.94, a PEG ratio of 2.22 and a beta of 0.98. Veeva Systems Inc. has a 1-year low of $201.54 and a 1-year high of $310.50. The company’s fifty day moving average price is $282.91 and its 200-day moving average price is $265.25.

Veeva Systems (NYSE:VEEVGet Free Report) last released its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). The business had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. Veeva Systems had a return on equity of 13.72% and a net margin of 27.29%.The firm’s revenue was up 16.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.62 EPS. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. Equities analysts anticipate that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Veeva Systems Company Profile

(Free Report)

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Featured Stories

Institutional Ownership by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.